Glen Eagle Advisors’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-25
| Closed | -$655 | – | 1051 |
|
|
2021
Q3 | $655 | Hold |
25
| – | – | ﹤0.01% | 1007 |
|
|
2021
Q2 | $800 | Hold |
25
| – | – | ﹤0.01% | 977 |
|
|
2021
Q1 | $880 | Hold |
25
| – | – | ﹤0.01% | 946 |
|
|
2020
Q4 | $802 | Hold |
25
| – | – | ﹤0.01% | 920 |
|
|
2020
Q3 | $941 | Hold |
25
| – | – | ﹤0.01% | 854 |
|
|
2020
Q2 | $1.12K | Hold |
25
| – | – | ﹤0.01% | 807 |
|
|
2020
Q1 | $853 | Hold |
25
| – | – | ﹤0.01% | 766 |
|
|
2019
Q4 | $975 | Buy |
+25
| New | +$975 | ﹤0.01% | 833 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 855 |
|